Pulmatrix Stock Technical Analysis

PULM Stock  USD 2.66  0.02  0.75%   
As of the 25th of January, Pulmatrix holds the Variance of 34.0, risk adjusted performance of (0.09), and Coefficient Of Variation of (770.66). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulmatrix, as well as the relationship between them. Please check Pulmatrix information ratio and skewness to decide if Pulmatrix is priced some-what accurately, providing market reflects its current price of 2.66 per share. Please also confirm Pulmatrix jensen alpha, which is currently at (0.72) to check out the company can sustain itself at a future point.

Pulmatrix Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pulmatrix, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PulmatrixPulmatrix's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Pulmatrix Analyst Consensus

Target PriceAdvice# of Analysts
10.0Buy1Odds
Pulmatrix current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Pulmatrix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pulmatrix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pulmatrix, talking to its executives and customers, or listening to Pulmatrix conference calls.
Pulmatrix Analyst Advice Details
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.71)
Revenue Per Share
0.001
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(0.79)
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pulmatrix 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pulmatrix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pulmatrix.
0.00
10/27/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/25/2026
0.00
If you would invest  0.00  in Pulmatrix on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding Pulmatrix or generate 0.0% return on investment in Pulmatrix over 90 days. Pulmatrix is related to or competes with Dare Bioscience, Hoth Therapeutics, Aspire BioPharma, Palisade Bio, Aditxt, Curis, and FibroBiologics Common. Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat r... More

Pulmatrix Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pulmatrix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pulmatrix upside and downside potential and time the market with a certain degree of confidence.

Pulmatrix Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pulmatrix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pulmatrix's standard deviation. In reality, there are many statistical measures that can use Pulmatrix historical prices to predict the future Pulmatrix's volatility.
Hype
Prediction
LowEstimatedHigh
0.132.638.64
Details
Intrinsic
Valuation
LowRealHigh
0.224.4810.49
Details
Naive
Forecast
LowNextHigh
0.063.079.08
Details
1 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details

Pulmatrix January 25, 2026 Technical Indicators

Pulmatrix Backtested Returns

Pulmatrix maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Pulmatrix exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pulmatrix's Variance of 34.0, coefficient of variation of (770.66), and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. The company holds a Beta of -0.72, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Pulmatrix are expected to decrease at a much lower rate. During the bear market, Pulmatrix is likely to outperform the market. At this point, Pulmatrix has a negative expected return of -0.78%. Please make sure to check Pulmatrix's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Pulmatrix performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.36  

Below average predictability

Pulmatrix has below average predictability. Overlapping area represents the amount of predictability between Pulmatrix time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pulmatrix price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Pulmatrix price fluctuation can be explain by its past prices.
Correlation Coefficient0.36
Spearman Rank Test0.02
Residual Average0.0
Price Variance0.51
Pulmatrix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Pulmatrix technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pulmatrix trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Pulmatrix Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pulmatrix volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Pulmatrix Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pulmatrix on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pulmatrix based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pulmatrix price pattern first instead of the macroeconomic environment surrounding Pulmatrix. By analyzing Pulmatrix's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pulmatrix's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pulmatrix specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2025 2026 (projected)
Dividend Yield0.140.13
Price To Sales Ratio3.763.57

Pulmatrix January 25, 2026 Technical Indicators

Most technical analysis of Pulmatrix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pulmatrix from various momentum indicators to cycle indicators. When you analyze Pulmatrix charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Pulmatrix January 25, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Pulmatrix stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Pulmatrix is a strong investment it is important to analyze Pulmatrix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmatrix's future performance. For an informed investment choice regarding Pulmatrix Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.71)
Revenue Per Share
0.001
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(0.79)
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.